Obesity and benign prostatic hyperplasia: Clinical connections, emerging etiological paradigms and future directions

Journal of Urology

Volumn 189, Issue 1 SUPPL, 2013, Pages

  Parsons, J Kellogg ^a   Sarma, Aruna V ^b   McVary, Kevin ^c   Wei, John T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Epidemiology ^*  (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

metabolic syndrome X; obesity; prostate; prostatic hyperplasia; urination disorders

Indexed keywords

ARTICLE; BODY MASS; HISTOPATHOLOGY; HUMAN; LOWER URINARY TRACT SYMPTOM; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUESTIONNAIRE; SYSTEMATIC REVIEW; URINE FLOW RATE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84870951537     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.029     Document Type: Article

References (43)

1. J.T. Wei, E. Calhoun, S.J. Jacobsen Urologic Diseases in America project: benign prostatic hyperplasia J Urol 173 2005 1256
2. G. Engstrom, L. Henningsohn, G. Steineck Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract BJU Int 95 2005 810
3. G. Engstrom, L. Henningsohn, M.L. Walker-Engstrom Impact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaire Scand J Urol Nephrol 40 2006 485
4. B.C. Taylor, T.J. Wilt, H.A. Fink Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study Urology 68 2006 804
5. J.K. Parsons, J. Mougey, L. Lambert Lower urinary tract symptoms increase the risk of falls in older men BJU Int 104 2009 63
6. J.K. Parsons Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems J Urol 178 2007 395
7. S. Haffner, H. Taegtmeyer Epidemic obesity and the metabolic syndrome Circulation 108 2003 1541
8. J.D. McConnell, C.G. Roehrborn, O.M. Bautista The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387
9. C.G. Roehrborn, J.D. McConnell, M. Lieber Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia Urology 53 1999 473
10. T. Soygur, B. Kupeli, K. Aydos Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels Int Urol Nephrol 28 1996 55
11. J.K. Parsons, H.B. Carter, A.W. Partin Metabolic factors associated with benign prostatic hyperplasia J Clin Endocrinol Metab 91 2006 2562
12. M.A. Joseph, J.T. Wei, S.D. Harlow Relationship of serum sex-steroid hormones and prostate volume in African American men Prostate 53 2002 322
13. S. Lee, H.G. Min, S.H. Choi Central obesity as a risk factor for prostatic hyperplasia Obesity (Silver Spring) 14 2006 172
14. A.V. Sarma, C.A. Jaffe, D. Schottenfeld Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men Urology 59 2002 362
15. S.J. Freedland, E.A. Platz, J.C. Presti Jr Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection J Urol 175 2006 500
16. E. Giovannucci, E.B. Rimm, C.G. Chute Obesity and benign prostatic hyperplasia Am J Epidemiol 140 1994 989
17. S.E. Dahle, A.P. Chokkalingam, Y.T. Gao Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia J Urol 168 2002 599
18. A.R. Kristal, K.B. Arnold, J.M. Schenk Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial J Urol 177 2007 1395
19. A. Zucchetto, A. Tavani, L. Dal Maso History of weight and obesity through life and risk of benign prostatic hyperplasia Int J Obes (Lond) 29 2005 798
20. J.P. Burke, T. Rhodes, D.J. Jacobson Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia Am J Epidemiol 164 2006 41
21. L. Fritschi, J. Tabrizi, J. Leavy Risk factors for surgically treated benign prostatic hyperplasia in Western Australia Public Health 121 2007 781
22. A. Gupta, S. Gupta, M. Pavuk Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans Urology 68 2006 1198
23. S. Rohrmann, E. Smit, E. Giovannucci Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey Am J Epidemiol 159 2004 390
24. A. Seim, C. Hoyo, T. Ostbye The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study BJU Int 96 2005 88
25. G. Haidinger, C. Temml, G. Schatzl Risk factors for lower urinary tract symptoms in elderly men Eur Urol 37 2000 413
26. M.A. Joseph, S.D. Harlow, J.T. Wei Risk factors for lower urinary tract symptoms in a population-based sample of African-American men Am J Epidemiol 157 2003 906
27. S.Y. Wong, J. Woo, A. Hong Risk factors for lower urinary tract symptoms in southern Chinese men Urology 68 2006 1009
28. P.H. Gann, C.H. Hennekens, C. Longcope A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia Prostate 26 1995 40
29. E.A. Platz, I. Kawachi, E.B. Rimm Physical activity and benign prostatic hyperplasia Arch Intern Med 158 1998 2349
30. J.B. Meigs, B. Mohr, M.J. Barry Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 54 2001 935
31. J. Hong, S. Kwon, H. Yoon Risk factors for benign prostatic hyperplasia in South Korean men Urol Int 76 2006 11
32. L. Dal Maso, A. Zucchetto, A. Tavani Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia Int J Cancer 118 2006 2632
33. S. Rohrmann, C.J. Crespo, J.R. Weber Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health and Nutrition Examination Survey BJU Int 96 2005 77
34. J.K. Parsons, C. Kashefi Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms Eur Urol 53 2008 1228
35. C.L. Ogden, M.D. Carroll, L.R. Curtin Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549
36. Public health and aging: trends in aging - United States and worldwide MMWR Morb Mortal Wkly Rep 52 2003 101
37. S. Furukawa, T. Fujita, M. Shimabukuro Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 2004 1752
38. J.C. Nickel, J. Downey, I. Young Asymptomatic inflammation and/or infection in benign prostatic hyperplasia BJU Int 84 1999 976
39. G. Theyer, G. Kramer, I. Assmann Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia Lab Invest 66 1992 96
40. J.T. Anim, C. Udo, B. John Characterisation of inflammatory cells in benign prostatic hyperplasia Acta Histochem 100 1998 439
41. F. Di Silverio, V. Gentile, A. De Matteis Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis Eur Urol 43 2003 164
42. S. Rohrmann, A.M. De Marzo, E. Smit Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III) Prostate 62 2005 27
43. J.L. St Sauver, D.J. Jacobson, M.E. McGree Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia Am J Epidemiol 164 2006 760